Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels
Clinical trial NCT06496243 · RECRUITING
Trial details
- NCT number
- NCT06496243
- Sponsor
- NewAmsterdam Pharma
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-02
- Primary completion
- 2026-11-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.